Navigation Links
Dr. Pittman of VEIN911 is Elected President of the Hillsborough County Medical Association
Date:6/23/2013

Tampa, FL (PRWEB) June 23, 2013

The HCMA is an organization of more than 1,400 physicians and medical students dedicated to the health of our community. HCMA is recognized as one of the most dynamic, successful and sophisticated county medical associations in Florida and has been a valuable local resource for Hillsborough County physicians since 1895.

“With the sweeping changes that health care reform legislation has brought upon physicians, the HCMA is a vital support system to our membership. As president, I look forward to continuing and expanding the growth and success of our HCMA and also developing leaders from among our members. HCMA keeps physicians informed of the newest changes in medicine and develops medical leaders, many who now serve at the state and national levels, providing exceptional benefits to our physician community and the patients we serve,” states Dr. Chris Pittman.

Dr. Pittman is a vein treatment specialist and expert in the diagnosis and non-surgical treatment of medical and cosmetic vein problems and is the Founder and Medical Director of VEIN911, a varicose vein treatment and spider vein treatment center in the Tampa Bay area. He has more than 20 years of experience performing minimally invasive, image guided surgery as a Vascular and Interventional Radiologist. Dr. Pittman is triple board-certified in Diagnostic Radiology, Vascular and Interventional Radiology, and Venous and Lymphatic Medicine.

“Dr. Pittman has been involved in organized medicine at the state and county level for many years. His selfless dedication has proven that he will be an asset in leading the endeavors of the Hillsborough County Medical Association,” says Debbie Zorian, Executive Director of HCMA. “I am confident that Dr. Pittman’s prominent leadership and innovative ideas will enhance the Association’s value to its membership, their patients, and the Tampa Bay community.”

About Dr. Christopher Pittman
Dr. Chris Pittman has more than 20 years of experience performing minimally invasive, image guided surgery. He is a fellowship-trained Vascular and Interventional Radiologist and formally educated venous disease expert, a vein treatment specialist, dedicated to total body diagnosis and treatment of medical and cosmetic vein disorders, such as spider veins and varicose veins.

Dr. Pittman is president of the Hillsborough County Medical Association and President-Elect of the Florida Medical Association Political Action Committee (FMA PAC). He is an active member of the American College of Phlebology and Florida Medical Association and delegate to the American Medical Association. Dr. Pittman is also a contributing author to “Healthy Veins . . . Healthy Legs: A Patient’s Guide to Phlebology.”

About VEIN911
VEIN911 has three vein treatment centers in the Tampa Bay area specializing in varicose vein treatment and spider vein treatment. The VEIN911 team is dedicated to the diagnosis and treatment of medical and cosmetic vein disorders. They are the only Tampa vein care specialists who exclusively evaluate and treat veins. To learn more about VEIN911, visit http://www.VEIN911.com.

About the Hillsborough County Medical Association
The Hillsborough County Medical Association, Inc., is an organization of more than 1,400 physicians and medical students dedicated to the health of our community. For more information about the HCMA, please visit http://www.HCMA.net.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10859345.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Hutchinson Center president elected to American Academy of Art and Sciences
2. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
3. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
4. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
5. ONR system selected to help DoD track human subjects studies
6. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
7. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
8. Wolters Kluwer Health selected as publisher for the Harvard Review of Psychiatry
9. Dr. Joan Miller selected to deliver the prestigious Edward Jackson Memorial Lecture
10. Mangos Selected by Liberty Sport as Advertising Agency Partner
11. Richard Mayeux, M.D., M.S., elected Fellow of AAAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, ... iSAFE Plus. These iSAFE products are the most affordable and most advanced medical alert ... offer direct GPS Location and two-way calling with the push of a button on ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") ... financial results for the year ended December 31, ... 2017. The results are being released later than ... statements will include the operations and balances of ... 2016.  This release and filing date meets TSX ...
(Date:3/28/2017)... March 28, 2017 The global emerging cancer ... of 13.45% from 2016 to 2023 and reach a ... Cancer is a chronic disease and is affecting ... cancer diagnostics market. This report is focused on emerging ... market growth is propelled due to factors such as: ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology: